查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2008666

动脉粥状硬化斑块切除术器械市场：按器械类型、操作模式、应用和最终用户划分 - 全球市场预测（2026-2032 年）

Atherectomy Devices Market by Device Type, Mode Type, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，动脉粥状硬化斑块切除术设备市场价值将达到 11.1 亿美元，到 2026 年将成长到 12 亿美元，到 2032 年将达到 20.2 亿美元，复合年增长率为 8.84%。

主要市场统计数据
预测年份（2025年） 11.1亿美元
基准年（2026 年） 12亿美元
预测年份（2032年） 20.2亿美元
复合年增长率（） 8.84%

全面介绍了器械创新、临床实践的变化以及对护理路径的需求如何重塑介入心臟病学家的动脉粥状硬化斑块切除术硬化切除术领域。

动脉粥状硬化斑块切除术装置在现代週边和冠状动脉介入医学中发挥着至关重要的作用，能够有效处理传统球囊血管成形术或支架置放术难以清除的钙化斑块和复杂动脉粥状硬化病变。临床上对精准斑块清除的需求，以及对提高手术效率和减少术后併发症的迫切需要，推动了这些装置的不断发展。创新技术涵盖机械式、定向式、轨道式和雷射系统，每种系统都旨在应对不同的病变形态和解剖结构挑战，同时适应临床医生的偏好和医疗机构的工作流程。

临床影像诊断、门诊护理和设备机制差异化的发展趋势，如何从根本上改变动脉粥状硬化动脉粥状硬化斑块切除术术的策略和实施趋势？

动脉粥状硬化斑块切除术领域的变革性变化反映了临床、技术和医疗服务趋势的融合，这些趋势正在重新定义该手术的范式。随着血管内影像和生理评估工具指南器械选择，临床医生正在采用更精准的病变管理策略，从而推动个人化治疗方案的实施，使器械机制能够适应斑块成分。这凸显了定向、雷射、轨道和旋转系统等不同类型器械差异化的重要性，每种类型都根据病变的复杂性和解剖结构特点，在临床应用领域占据着特定的地位。

美国关税变更将于 2025 年生效，这将对医疗设备相关人员的采购、製造和临床部署途径产生营运和采购方面的影响。

美国2025年实施的关税调整对整个医疗设备供应链的运作提出了具体要求，影响到动脉粥状动脉粥状硬化斑块切除术系统关键零件、资本设备和外围耗材的进口。这些关税调整迫使製造商重新评估其筹资策略，优先确保区域供应的连续性，并加快与契约製造製造商的磋商，以稳定生产计划。对于依赖美国境外专业零件和组装流程的公司而言，这种调整尤其显着，迫使它们进行近岸外包并实现供应商组合多元化。

关键细分洞察揭示了设备的机制、临床适应症、临床环境和操作模式如何全面影响其临床应用和商业性定位。

细分市场分析揭示了不同设备类型、临床应用、终端用户环境和操作模式下的细微实施动态，从而为临床策略和商业性重点提供了深刻见解。定向系统、雷射系统、轨道系统和旋转系统等不同设备类型反映了其不同的操作特性。定向系统通常用于精确清除偏心病变中的斑块；雷射系统在某些纤维化和钙化病变中具有独特的优势；轨道系统可透过差异切割实现环週斑块清除；而旋转系统则因其操作简便且在特定病变类型中表现可靠而被广泛采用。这些机制上的差异会影响训练需求、治疗计画和辅助设备的选择。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势正在塑造临床路径、监管方法和商业性合作策略。

区域趋势对动脉粥状硬化斑块切除术器械的临床实践模式、监管方法和商业策略有着显着影响，美洲、欧洲、中东和非洲以及亚太地区呈现出不同的特征。在美洲，先进的血管内治疗计画和完善的介入专家网络塑造了临床路径，导致三级医疗机构的手术量庞大，门诊处理量也随之增加。该地区的报销框架和供应链因素影响采购週期，因此能够提供全面培训和全生命週期支援的合作伙伴更受青睐。

製造商如何透过临床训练、服务模式和综合平台策略展开竞争，从而影响治疗方法的采用和长期客户关係？

医疗设备製造商之间的竞争格局不再仅仅围绕器材本身的机制展开，还涵盖了培训、循证医学证据的累积、上市后监测以及一体化服务交付。主要企业正在投资临床教育计画、介入团队的实践培训以及支持患者选择和手术计划的数位化工具。这些措施有助于降低器械应用门槛，并增强医务人员在不同器械类型之间转换时的信心。策略伙伴关係和分销模式也在不断发展，製造商与医疗系统、培训中心和影像设备供应商合作，建立涵盖从计划到追踪整个手术流程的捆绑式解决方案。

为医疗设备製造商和临床领导者提供实用建议，以协调培训、供应链韧性和证据产生与区域医疗保健服务优先事项。

产业领导者应采取多管齐下的方法，将器材创新与临床教育、区域适应性和稳健的供应链结合。首先，他们应优先投资于综合性的临床医生培训项目，这些项目应结合模拟、指导和案例学习，以加速定向、雷射、轨道和旋转平台的安全部署。将血管内影像训练与器械教育结合，将使临床医生能够优化患者选择和手术流程，减少治疗结果的差异，并为特定器械的治疗方法建立更有力的临床证据。

结合对临床医生的访谈、对二手文献的回顾以及反覆的专家检验，采用综合调查方法，确保获得具有丰富背景和可操作性的见解。

本分析的调查方法融合了第一手和第二手调查、定性专家对话以及反覆检验，以确保获得稳健且具有丰富背景资讯的洞见。第一手资料透过介入心臟科医师、血管外科医师、导管室主管、采购经理和门诊手术中心管理人员的结构化访谈和咨询收集，以获得关于器械性能、手术流程和推广障碍的第一手观点。除了这些以临床医生为中心的对话外，对监管和报销专家的访谈也揭示了影响器械推广的政策因素和采购趋势。

对临床需求、营运实际情况和策略性商业性参与将如何推动动脉粥状硬化斑块切除术的下一阶段应用进行全面分析和得出结论。

对器械机制、临床路径、区域趋势和商业策略的全面分析表明，动脉粥状硬化斑块切除术器械正从利基工具转变为以通讯协定主导的血管治疗中的战略组成部分。临床团队将继续寻求能够在各种病变类型中提供可预测性能、与影像和栓塞预防策略无缝集成，并提供培训资源以减少治疗结果差异的平台。在操作层面，随着某些手术转移到门诊和日间住院环境中，支援处理能力、安全性和当日出院流程的器械将变得越来越重要。

目录

第一章 引言

第二章 分析方法

  • 分析设计
  • 分析框架
  • 市场规模预测
  • 数据三角测量
  • 分析结果
  • 分析的前提条件
  • 分析的局限性

第三章执行摘要

  • 首席体验长的观点
  • 市场规模和成长趋势
  • 市占率分析（2025 年）
  • FPNV定位矩阵（2025）
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入（GTM）策略

第五章 市场洞察

  • 消费者分析与最终用户观点
  • 消费者体验基准测试
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第六章：美国关税的累积影响（2025 年）

第七章：人工智慧（AI）的累积影响（2025 年）

第八章：动脉粥状硬化斑块切除术设备市场：依设备类型划分

  • 方向
  • 雷射
  • 轨道
  • 旋转

第九章：动脉动脉粥状硬化斑块切除术器械市场：依操作模式划分

  • 连续型
  • 间歇性

第十章：动脉粥状硬化斑块切除术器械市场：依应用领域划分

  • 冠状动脉
  • 外围
    • 颈动脉
    • 下肢
      • 腘动脉
      • 表动脉

第十一章动脉粥状硬化斑块切除术器械市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所
    • 门诊血管中心
    • 血管检查室

第十二章 动脉动脉粥状硬化斑块切除术器械市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 动脉动脉粥状硬化斑块切除术器械市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章动脉粥状硬化斑块切除术设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国动脉粥状硬化斑块切除术器械市场

第十六章：中国动脉动脉粥状硬化斑块切除术器械市场

第十七章 竞争格局

  • 市场集中度分析（2025 年）
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析（2025 年）
  • 产品系列分析（2025 年）
  • 基准分析（2025 年）
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Avinger, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • ConMed Corporation
  • Cook Medical LLC
  • INVAMED
  • Koninklijke Philips NV
  • Medtronic plc
  • NEScientific, Inc
  • NIPRO CORPORATION
  • OrbusNeich Medical Company Limited
  • RA Medical Systems, Inc.
  • Terumo Corporation
Product Code: MRR-8E22B61932A8

The Atherectomy Devices Market was valued at USD 1.11 billion in 2025 and is projected to grow to USD 1.20 billion in 2026, with a CAGR of 8.84%, reaching USD 2.02 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.11 billion
Estimated Year [2026] USD 1.20 billion
Forecast Year [2032] USD 2.02 billion
CAGR (%) 8.84%

Comprehensive introduction to how device innovation, clinical practice shifts, and care pathway demands are reshaping the atherectomy landscape for interventional specialists

Atherectomy devices occupy a pivotal role in contemporary peripheral and coronary interventional practice, addressing calcified and complex atherosclerotic lesions where conventional balloon angioplasty and stenting may be insufficient. The clinical imperative for precision plaque modification, coupled with procedural efficiency and the desire to minimize downstream complications, has driven continuous device evolution. Innovations span mechanical, directional, orbital, and laser-based systems, each engineered to meet distinct lesion morphology and anatomic challenges while aligning with operator preferences and institutional workflows.

Beyond device mechanics, stakeholder expectations now encompass integrated solutions that reduce procedure time, mitigates embolic risk, and facilitate same-day discharge pathways. Reimbursement environments, procedural guidelines, and growing demand for ambulatory-based interventions are reshaping where and how these devices are deployed. As clinical teams pursue optimal patient outcomes, they increasingly weigh comparative procedural safety, ease of use, training needs, and post-procedural care implications when selecting atherectomy approaches.

The introduction of next-generation mode strategies, including continuous and intermittent operation types, and the refinement of adjunctive technologies such as embolic protection and intravascular imaging, further diversify the decision matrix. Consequently, device manufacturers, clinical leaders, and health system purchasers must navigate a nuanced landscape where clinical efficacy, operational adaptability, and regulatory alignment determine the strategic choices that influence procedural pathways and patient care trajectories.

How clinical imaging, outpatient care trends, and device mechanism differentiation are driving a fundamental shift in atherectomy procedural strategies and adoption dynamics

Transformative shifts in the atherectomy domain reflect a confluence of clinical, technological, and care-delivery trends that are redefining procedural paradigms. Clinicians are adopting more precise lesion-preparation strategies as intravascular imaging and physiologic assessment tools inform device selection, thereby promoting tailored approaches that match device mechanism to plaque composition. This has elevated the importance of device differentiation across directional, laser, orbital, and rotational systems, with each class carving specific clinical niches based on lesion complexity and anatomical considerations.

Simultaneously, care-delivery models are moving toward outpatient and ambulatory settings, prompting device development to prioritize user ergonomics, reduced procedure duration, and compatibility with same-day discharge protocols. The interplay between device mode types-continuous versus intermittent-affects heat generation, debris management, and operator technique, prompting manufacturers to innovate around safety features and adjunctive embolic-protection strategies. Furthermore, cross-disciplinary collaboration between vascular surgeons, interventional cardiologists, and radiologists is accelerating hybrid procedural approaches that leverage complementary device platforms.

On the commercial front, competitive dynamics are intensifying as companies emphasize service offerings, training programs, and bundled solutions to lower adoption barriers. Regulatory scrutiny and evolving reimbursement frameworks have also prompted companies to demonstrate clear clinical value propositions and to invest in real-world evidence generation. Collectively, these shifts are expanding the operational role of atherectomy devices beyond niche interventions into broader, protocol-driven care pathways that prioritize predictable outcomes and procedural efficiency.

Operational and procurement implications of the United States tariff changes in 2025 that are reshaping sourcing, manufacturing, and clinical adoption pathways for device stakeholders

United States tariff changes enacted in 2025 have imposed tangible operational considerations across medical device supply chains, affecting components, capital equipment imports, and peripheral consumables integral to atherectomy systems. The tariff adjustments have prompted manufacturers to re-evaluate sourcing strategies, prioritize regional supply continuity, and accelerate discussions with contract manufacturers to insulate production timelines. This recalibration has been most pronounced for companies that rely on specialized components or assembly operations located outside the United States, prompting nearshoring and diversification of supplier portfolios.

In response, procurement teams at hospitals, ambulatory surgical centers, and specialty clinics have increased focus on inventory management, contract terms, and total cost of ownership when selecting device platforms. Device makers have pursued cost optimization through recalibrated bills of materials, design simplification where clinically feasible, and selective localization of high-value components. These measures have been complemented by intensified dialogues between manufacturers and health systems to explore consignment models, managed inventory programs, and bundled purchasing arrangements that mitigate tariff-driven price volatility.

The policy shift has also stimulated renewed emphasis on lifecycle support and service-based revenue streams, as companies seek to sustain margins while offering predictable procurement options. Importantly, clinicians and supply chain leaders are working together to ensure that clinical efficacy and patient safety remain paramount while navigating operational adjustments prompted by the tariff landscape, leading to pragmatic trade-offs and phased implementation strategies for devices and consumables.

Key segmentation insights revealing how device mechanism, clinical indication, care setting, and operational mode collectively shape clinical adoption and commercial positioning

Segmentation insights reveal nuanced adoption dynamics across device types, clinical applications, end-user settings, and mode types that inform both clinical strategy and commercial focus. Device-type distinctions between directional, laser, orbital, and rotational systems reflect divergent operational profiles: directional systems are often favored for precise plaque modification in eccentric lesions, laser systems provide unique advantages in certain fibro-calcific anatomies, orbital platforms enable circumferential plaque sanding with differential cutting action, and rotational systems are commonly chosen for their familiarity and established performance in select lesion sets. These mechanistic differences shape training requirements, procedure planning, and adjunctive device selection.

Application segmentation underscores distinct coronary and peripheral pathways. Coronary interventions typically prioritize lumen restoration in small-caliber, high-flow vessels, whereas peripheral procedures demand versatility across larger vessels and varied lesion morphologies. Within the peripheral pathway, specific attention to carotid interventions and lower limb arteries directs clinical decision-making; lower limb strategies further differentiate between popliteal artery and superficial femoral artery interventions due to anatomic mobility, vessel size, and biomechanical stressors. End-user segmentation highlights the influence of care setting on device choice and procedural logistics. Ambulatory surgical centers emphasize throughput and same-day discharge compatibility, hospitals prioritize range of device capabilities and backup resources, and specialty clinics focus on vascular-centric workflows; within specialty clinics, outpatient vascular centers and vascular labs each face different staffing and imaging infrastructure considerations that influence device deployment.

Mode type segmentation between continuous and intermittent operation influences procedural technique and safety profiles. Continuous systems can offer steady-state performance suitable for specific plaque morphologies, while intermittent systems may provide thermal management advantages and different debris characteristics. Collectively, these segmentation layers inform go-to-market strategies, clinical training programs, and the development of value propositions tailored to the unique demands of operators and institutions across clinical and geographic contexts.

Regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine clinical pathways, regulatory approaches, and commercial engagement strategies

Regional dynamics exert a powerful influence on clinical practice patterns, regulatory approaches, and commercial strategies for atherectomy devices, with distinct characteristics observable across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, clinical pathways are shaped by advanced endovascular programs and established networks of interventional specialists, leading to high procedural volumes in tertiary hospitals and growing throughput in ambulatory settings. Reimbursement frameworks and supply chain considerations within this region influence procurement cadence and favor partners that can provide robust training and lifecycle support.

The Europe, Middle East & Africa region displays heterogeneous regulatory environments and healthcare delivery models, which necessitate adaptable market approaches. Western European centers typically emphasize evidence-based adoption, integration with intravascular imaging, and multidisciplinary procedural planning, while other markets within the broader region may prioritize cost-effective solutions and scalable training programs. Regulatory timelines and national procurement practices are critical variables that shape entry strategies and product positioning.

Asia-Pacific presents diverse opportunities driven by expanding cardiovascular care infrastructure, rapid adoption of minimally invasive techniques, and a mix of public and private healthcare delivery. In several markets, increasing procedure volumes for peripheral arterial disease and investments in catheterization facilities are creating demand for versatile device portfolios. Across all regions, manufacturers and clinical leaders must reconcile global product platforms with local clinical workflows, regulatory requirements, and reimbursement realities, employing differentiated engagement models that align training, service, and commercial support with regional priorities.

How manufacturers are competing through clinical training, service models, and integrated platform strategies to influence procedural adoption and long-term customer relationships

Competitive dynamics among device manufacturers now hinge on more than device mechanics; they encompass training, evidence generation, post-market surveillance, and integrated service offerings. Leading companies are investing in clinical education programs, hands-on training for interventional teams, and digital tools that support patient selection and procedural planning. These capabilities help lower barriers to adoption and increase procedural confidence among operators transitioning between device classes. Strategic partnerships and distribution models are also evolving, with manufacturers collaborating with health systems, training centers, and imaging vendors to create bundled solutions that address entire procedural pathways from planning through follow-up.

Product development investments are channeling into platform versatility, adjunctive safety features such as embolic-protection compatibility, and minimally invasive access enhancements. Companies are also leveraging real-world evidence initiatives and registry participation to strengthen clinical narratives and to support payer discussions centered on outcomes and resource utilization. Service differentiation through managed inventory, on-site technical support, and outcome-focused training has become a key competitive lever, especially in settings where procedural throughput and cost predictability influence purchasing decisions.

Given the intersection of clinical requirements and operational constraints, market players that align product design, clinician training, and post-sales support with institutional workflows are best positioned to influence long-term procurement decisions. Those that emphasize interoperability with intravascular imaging and ancillary devices, demonstrate reproducible clinical outcomes, and deliver scalable education programs will maintain a durable advantage in complex account environments.

Actionable recommendations for device makers and clinical leaders to align training, supply-chain resilience, and evidence generation with regional care delivery priorities

Industry leaders should adopt a multi-pronged approach that aligns device innovation with clinical education, regional adaptability, and resilient supply chains. First, prioritize investments in comprehensive clinician training programs that combine simulation, proctorship, and case-based learning to accelerate safe adoption across directional, laser, orbital, and rotational platforms. Embedding intravascular imaging training alongside device education will help clinicians optimize patient selection and procedural techniques, reducing variability in outcomes and building stronger clinical evidence for device-specific approaches.

Second, bolster supply-chain resilience by diversifying component sourcing, considering nearshoring of critical assemblies, and negotiating flexible procurement terms with health-system partners. These actions will mitigate the operational uncertainties introduced by trade-policy shifts and support predictable device availability. Third, tailor regional strategies to local regulatory and reimbursement landscapes by offering adaptable commercial models such as managed inventory, outcome-based contracting pilots, and localized service hubs that address the unique needs of ambulatory surgical centers, hospitals, and specialty clinics, including outpatient vascular centers and vascular labs.

Fourth, invest in real-world evidence programs and registries that capture procedural outcomes across coronary and peripheral indications, with attention to lesion subsets such as carotid and lower limb interventions involving the popliteal artery and superficial femoral artery. Finally, design product roadmaps that balance performance improvements with simplicity of use, emphasizing safety features for continuous and intermittent mode types to meet diverse operator preferences. This integrated approach will help manufacturers and clinical leaders translate innovation into sustainable adoption and improved patient care pathways.

Integrated research methodology combining clinician interviews, secondary literature review, and iterative expert validation to ensure context-rich and actionable insights

The research methodology underpinning this analysis integrates a blended approach of primary and secondary investigation, qualitative expert engagement, and iterative validation to ensure robust, context-rich insights. Primary inputs included structured interviews and consultations with interventional cardiologists, vascular surgeons, cath lab directors, procurement leaders, and ambulatory surgical center managers to capture firsthand perspectives on device performance, procedural workflow, and adoption barriers. These clinician-centered dialogues were complemented by interviews with regulatory and reimbursement specialists to illuminate policy drivers and procurement dynamics that influence device deployment.

Secondary research encompassed a systematic review of peer-reviewed literature, clinical guidelines, procedure registries, and product technical specifications to map device mechanisms, safety profiles, and clinical use cases across coronary and peripheral applications. The analysis also considered device labeling, regulatory clearances, and published outcomes data to contextualize clinical narratives. Qualitative synthesis methods were applied to reconcile sometimes divergent practitioner perspectives and to surface common themes related to training needs, adjunctive technologies, and care-setting suitability.

Finally, findings were iteratively validated through expert panel reviews and cross-checked against publicly available clinical evidence and procedural best-practice guidance. This triangulated methodology ensured that conclusions reflect current clinical realities, operational constraints, and the strategic priorities of stakeholders across ambulatory surgical centers, hospitals, and specialty clinics including outpatient vascular centers and vascular labs.

Synthesis and concluding perspectives on how clinical demand, operational realities, and strategic commercial engagement will drive the next phase of atherectomy adoption

The cumulative analysis of device mechanisms, clinical pathways, regional dynamics, and commercial strategies indicates that atherectomy devices are transitioning from niche tools to strategic components of protocol-driven vascular care. Clinical teams will continue to demand platforms that offer predictable performance across diverse lesion types, seamless integration with imaging and embolic-protection strategies, and training resources that reduce variability in outcomes. Operationally, the migration of selected procedures to ambulatory and outpatient environments will place a premium on devices that support throughput, safety, and same-day discharge workflows.

Commercially, manufacturers that combine product innovation with robust post-sales support, flexible procurement models, and targeted evidence generation will be better positioned to influence long-term device selection. Supply-chain adjustments prompted by recent policy changes highlight the importance of sourcing flexibility and service-based offerings that maintain continuity of care. Looking ahead, collaborative initiatives between clinical leaders, device makers, and health systems that emphasize outcomes, cost efficiency, and clinician proficiency will shape the next phase of atherectomy adoption and standardization.

Ultimately, success in this evolving landscape will depend on the alignment of clinical efficacy, operational adaptability, and strategic commercial engagement to deliver measurable improvements in patient care while accommodating the practical constraints of contemporary healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Atherectomy Devices Market, by Device Type

  • 8.1. Directional
  • 8.2. Laser
  • 8.3. Orbital
  • 8.4. Rotational

9. Atherectomy Devices Market, by Mode Type

  • 9.1. Continuous
  • 9.2. Intermittent

10. Atherectomy Devices Market, by Application

  • 10.1. Coronary
  • 10.2. Peripheral
    • 10.2.1. Carotid
    • 10.2.2. Lower Limb
      • 10.2.2.1. Popliteal Artery
      • 10.2.2.2. Superficial Femoral Artery

11. Atherectomy Devices Market, by End-User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospitals
  • 11.3. Specialty Clinic
    • 11.3.1. Outpatient Vascular Center
    • 11.3.2. Vascular Lab

12. Atherectomy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Atherectomy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Atherectomy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Atherectomy Devices Market

16. China Atherectomy Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. AngioDynamics, Inc.
  • 17.7. Avinger, Inc.
  • 17.8. B. Braun SE
  • 17.9. Becton, Dickinson and Company
  • 17.10. Boston Scientific Corporation
  • 17.11. Cardiovascular Systems, Inc.
  • 17.12. ConMed Corporation
  • 17.13. Cook Medical LLC
  • 17.14. INVAMED
  • 17.15. Koninklijke Philips N.V.
  • 17.16. Medtronic plc
  • 17.17. NEScientific, Inc
  • 17.18. NIPRO CORPORATION
  • 17.19. OrbusNeich Medical Company Limited
  • 17.20. RA Medical Systems, Inc.
  • 17.21. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ATHERECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ATHERECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ATHERECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY DIRECTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ORBITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY ROTATIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY CAROTID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY POPLITEAL ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SUPERFICIAL FEMORAL ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY OUTPATIENT VASCULAR CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY VASCULAR LAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ATHERECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ATHERECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ATHERECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ATHERECTOMY DEVICES MARKET SIZE, BY MODE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ATHERECTOMY DEVICES MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ATHERECTOMY DEVICES MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ATHERECTOMY DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ATHERECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)